A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience

Arab Journal of Gastroenterology

Volumn 14, Issue 4, 2013, Pages 158-164

  Hassan, Elham Ahmed ^a   Abd El Rehim, Abeer Sharaf El Din ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

1 Year survival; Cirrhosis related complications; CrCTP score; Prognostic models; Sodium based MELD variants

Indexed keywords

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EGYPT; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATOBILIARY RADIOGRAPHY; HEPATORENAL SYNDROME; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; MORTALITY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; STOMACH VARICES BLEEDING; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

1-YEAR SURVIVAL; CIRRHOSIS-RELATED COMPLICATIONS; CRCTP SCORE; PROGNOSTIC MODELS; SODIUM-BASED MELD VARIANTS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EGYPT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; YOUNG ADULT;

EID: 84892480953     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2013.08.007     Document Type: Article

References (35)

1. Durand F., Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh vs. MELD. J Hepatol 2005, 42:S100-S107.
2. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD). Hepatology 2007, 45:797-805.
3. Delolmo J.A., Pena A., Serram A., et al. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000, 32:19.
4. Said A., Williams J., Holden J., et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004, 40:897-903.
5. Biggins S.W., Kim W.R., Saab T.S., et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006, 130:1652-1660.
6. Heuman D.M., Abou-assi S.G., Habib A., et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004, 40:802-810.
7. Luca A., Angermayr B., Bertolini G., et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007, 13:1174-1180.
8. Ripoll C., Bãnares R., Rinc ́on R., et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology 2005, 42:793-801.
9. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60(8):646-649.
10. Papatheodoridis G.V., Cholongitas E., Dimitriadou E., et al. MELD vs. Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005, 11:3099-3104.
11. Wiesner R.H., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
12. Kim W.R., Biggins S.W., Kremers W.K., et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008, 359:1018-1026.
13. Luca A., Angermayr B., Bertolini G., et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality inpatients with cirrhosis. Liver Transpl 2007, 13:1174-1180.
14. Huo T.I., Wang Y.W., Yang Y.Y., et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007, 27:498-506.
15. Zhang Q.B., Chen Y.T., Lian G.D., Qian C.C., et al. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clin Res Hepatol Gastroenterol 2012, http://dx.doi.org/10.1016/j.clinre.2012.04.014.
16. Testa R., Valente U., Risso D., et al. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosisα. Eur J Gastroenterol Hepatol 1999, 11(5):559-563.
17. Forman L.M., Lucey M.R. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology 2001, 33:473-475.
18. Freeman R.B., Wiesner R.H., Edwards E., et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004, 10:7-15.
19. Boursier J., Cesbron E., Tropet A.L., et al. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009, 43:580-585.
20. Causey M.W., Steele S.R., Farris Z., et al. An assessment of different scoring systems in cirrhotic patients undergoing non transplant surgery. Am J Surg 2012, 203:589-593.
21. Huo T.I., Lin H.C., Wu J.C., et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006, 20:188-194.
22. Wong V.W., Chim A.M., Wong G.L., et al. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl 2007, 13:1228-1235.
23. Ruf A.E., Kremers W.K., Chavez L.L., et al. Addition of serum sodium into the MELD score predicts waiting list mortality be lower than MELD alone. Liver Transpl 2005, 11:336-343.
24. Porcel A., Díaz F., Rendón P., et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002, 162:323-328.
25. Londoño M.C., Cárdenas A., Guevara M., et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007, 56:1283-1290.
26. Arroyo V., Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003, 38(Suppl. 1):S69-89.
27. Borroni G., Maggi A., Sangiovanni A., et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 2000, 32:605-610.
28. Albillos A., Colombato L.A., Groszmann R.J. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992, 102:931-935.
29. Chawla Y.K., Kashinath R.C., Duseja A., et al. Predicting mortality across a broad spectrum of liver disease-An assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and creatinine-modified CTP scores. J Clin Exp Hepatol 2011, 1:161-168.
30. Angermayr B., Cejna M., Karnel F., et al. Child-Pugh vs. MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003, 52:879-885.
31. Pagliaro L. MELD: the end of Child-Pugh classificationα. J Hepatol 2002, 36:141-142.
32. Saab S., Niho H., Comulada S., et al. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver Int 2005, 25:940-945.
33. Choi P.C., Kim H.J., Choi W.H., et al. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver Int 2009, 29:221-226.
34. Wei-ping H.E., Jin-hua H.U., Jun Z., et al. Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure. Chin Med J 2012, 125(13):2272-2278.
35. Fontana R.J., Hann H.W., Perrillo R.P., et al. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology 2002, 123:719-727.